MedTrace Logo

The THINK Study Incidence of Neurotrophic Keratopathy)

NCT06482164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2026-03-31

No results posted yet for this study

Summary

The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.

Conditions

  • Dry Eye

Interventions

DIAGNOSTIC_TEST

Dry Eye Disease

Corneal sensitivity in patients who also have dry eye.

Sponsors & Collaborators

  • Research Insight LLC

    lead INDUSTRY

Principal Investigators

  • John Hovanesian, MD · Harvard Eye Associates

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-18
Primary Completion
2024-08-07
Completion
2024-08-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482164 on ClinicalTrials.gov